Press Releases

Our enduring purpose: to fundamentally improve the lives of patients with serious diseases in ways never before possible.

Press Releases

Date	Title
August 6, 2020	Five Prime Therapeutics Reports Second Quarter 2020 Results
July 29, 2020	Five Prime Therapeutics to Participate in the 2020 Wedbush PacGrow Healthcare Virtual Conference
July 29, 2020	Five Prime Therapeutics Announces Timing of Its Second Quarter 2020 Results Conference Call
May 7, 2020	Five Prime Therapeutics Reports First Quarter 2020 Results
April 30, 2020	Five Prime Therapeutics Announces Timing of Its First Quarter 2020 Results Conference Call
April 22, 2020	Five Prime Therapeutics Changes 2020 Annual Meeting to Virtual Format
April 14, 2020	Five Prime Therapeutics Appoints Tom Civik as Chief Executive Officer
March 13, 2020	Five Prime Therapeutics Announces Publication of the Phase 1 Bemarituzumab Study in the Journal of Clinical Oncology
February 27, 2020	Five Prime Therapeutics Reports Fourth Quarter and Full Year 2019 Results
February 25, 2020	Five Prime Therapeutics to Present at Upcoming Healthcare Conference

Print Page

RSS Feeds

E-Mail Alerts

Contact IR

© 2020 Five Prime Therapeutics, Inc. All rights reserved

Website Design: Hane Chow, Inc.